SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 29, 16:30
3359.20
121.1 (3.74%)
VOLUME 78,554
LIVE
NSE
Jan 29, 16:30
3363.30
124.25 (3.84%)
VOLUME 1,401,638
Management Interviews on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Russia's impact not fully played out in Q3: Dr Reddy's

5.07 pm | 29 Jan 2015 |  Source: CNBC-TV18

Dr Reddy's Laboratories beat street expectations on both topline and bottomline but operating performance was below estimates. Consolidated net profit...

Core generics, API biz to drive FY16 growth: Dr Reddy's 

10.17 am | 12 Jan 2015 |  Source: CNBC-TV18

GV Prasad, Co-Chairman & CEO of Dr Reddy’s Laboratories said a lot of growth is seen in emerging markets...

Sun's margins may reduce to 30-32% post merger: Surajit Pal 

12.36 pm | 29 Dec 2014 |  Source: CNBC-TV18

As 2014 comes to an end, Surajit Pal of Prabhudas Lilladher shares his outlook on the year that was and the possible trends for 2015....

Likely to file 2 NDAs worth $100 m each soon: Dr Reddy's 

4.51 pm | 29 Oct 2014 |  Source: CNBC-TV18

Discussing the company’s results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He ...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.